Comparison of Hysterosalpingography and Hysteroscopy in Evaluating the Uterine Cavity in Infertile Women

Total Page:16

File Type:pdf, Size:1020Kb

Comparison of Hysterosalpingography and Hysteroscopy in Evaluating the Uterine Cavity in Infertile Women MOJ Women’s Health Research Article Open Access Comparison of hysterosalpingography and hysteroscopy in evaluating the uterine cavity in infertile women Abstract Volume 8 Issue 1 - 2019 Background: Infertility in women is predominantly associated with uterine cavity Baydaa F Alsannan,1 Ghadeer S Akbar,2 abnormalities. Uterine cavity anomalies and damage to the fallopian tubes may occur 3 due to various reasons such as endometriosis, polyps, adhesions and scar tissues. Anthony P Cheung 1Department of Obstetrics and Gynecology, University of Objective: To investigate the diagnostic value of hysterosalpingography (HSG) in Kuwait, Kuwait comparison to hysteroscopy (HSC) for various structural and intracavitary uterine 2Department of Obstetrics and Gynecology, Ministry of Health, pathologies in women with infertility. Kuwait 3Department of Reproductive Endocrinology and Infertility, Materials and methods: An observational study of 280 women with infertility was University of British Colombia, Canada carried out to compare the diagnostic values of HSG and HSC in the diagnosis of uterine pathologies in women enduring infertility. The specific uterine conditions Correspondence: Baydaa Al Sannan, Department of evaluated were intrauterine synechiae, intrauterine fibroids/polyps and Mullerian Obstetrics and Gynecology, Faculty of medicine, Kuwait congenital anomalies. The main outcome measures were sensitivity, specificity, University, Kuwait, Tel +965 25319601, positive and negative predictive values of HSG relative to hysteroscopy in diagnosing Email the following uterine pathologies: intrauterine synechiae, intrauterine fibroids/polyps Received: December 18, 2018 | Published: January 16, 2019 and Mullerian anomalies. Results: HSG had a sensitivity of 75% in detecting intrauterine synechiae, specificity of 86.5%, positive predictive value of 63% and negative predictive value of 91.8%. For fibroids or polyps, the equivalent values were 82.3%, 40.9%, 56.4% and 71.4%. Finally, for Mullerian congenital anomalies, the corresponding values were 86.6%, 76.3%, 48.1% and 95.7%. The study has indicated that the HSG remains a useful screening test in evaluating the uterine cavity of infertile women. Conclusion: It has been subsequently concluded that HSG remains a valuable screening modality for the evaluation of uterine cavity of infertile women if office sonohysteroscopy or hysteroscopy is not available in absence of tubal pathology. HSG was an ideal procedure to detect intrauterine synechiae, fibroids and to a lesser extent, congenital Mullerian abnormalities. Hysteroscopy should be considered to make a definitive diagnosis and treatment. These two procedures are complementary to each other in evaluation of uterine cavity. Keywords: infertility, hysterosalpingography, hysteroscopy, fibroids, tubal, pathology Introduction Hysterosalpingography (HSG), and Hysteroscopy (HSC). Hysteroscopy (HSC) and Hysterosalpingography (HSG) are used Infertility in women related to uterine cavity abnormalities has for screening purposes in routine infertility evaluation.4 They are been persistent in approximately 34%–62% of infertile women. There used in many infertility centers as an initial investigation tool are a host of reasons that cause female infertility and prevent normal to find the exact cause of the inability to conceive a child. As the conception. Approximately 15% of women enduring infertility suffer name indicates, Transvaginal Sonography (TVS) comprises of a uterine abnormalities, while between 30-40% are shown to have transvaginal ultrasound that examines the reproductive organs of a tubal pathologies as a cause of their infertility. Some of the uterine female that might include the fallopian tubes, cervix, uterus, ovaries abnormalities that are responsible for infertility are intrauterine and vagina. It is a common routine modality that is used to detect 1 adhesions, uterine fibroids and endometrial polyps. Apart from this, the cause of infertility in women. However, uterine abnormalities 20%-40% of women infertility is related to their male counterpart such as submucous fibroids, adhesions and polyps are difficult to 2 and between 20%-40% is found to have ovulatory dysfunction. diagnose with this procedure. Furthermore, transvaginal sonography Comprehensive and detailed evaluation is imperative to explore the shows poor positive predictive value (PPV) rates and poor sensitivity, 3 exact cause of the infertility. Some of the pre-treatment evaluations particularly in the diagnosis of polypoid adhesions.5 include physical examination, hormonal testing and imaging to examine the uterus, endometrium, and fallopian tubes for anomalies Diagnostic hysteroscopy is a safe procedure, which is performed or abnormalities, which might be potentially preventing normal to evaluate the uterine cavity in infertile women and to ascertain the conception. cause of infertility. Hysteroscopy is a diagnostic modality in which the endometrium, which is the inner lining of the uterus; is seen with The standard method for assessing these structures a camera that is placed in the cervix of a patient.6 In addition, it is classically involves a blend of Transvaginal Sonography (TVS), also performed to decide the cause of repeated miscarriages or to help Submit Manuscript | http://medcraveonline.com MOJ Womens Health. 2019;8(1):46‒49. 46 ©2019 Alsannan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and build upon your work non-commercially. Copyright: Comparison of hysterosalpingography and hysteroscopy in evaluating the uterine cavity in infertile women ©2019 Alsannan et al. 47 locate uterine abnormalities such as polyps and fibroids. Hysteroscopy In another study by Phillips13 three diagnostic approaches were is used as a diagnostic, a treatment and a management tool.7 used to compare the uterine and tubal pathologies of infertile women. The three diagnostic procedures were transvaginal sonography, HSG has been the most commonly used investigative technique hysteroscopy and hysterosalpingography. Out of the 1274 patients in the diagnosis of both congenital and acquired intrauterine that received baseline TVS, 327 participants undertook the HSG abnormalities.8 HSG is the examination of a woman’s uterus with the test and out of which, 55 endured the HSC procedure. The results help of an x-ray. However, it employs a different form of x-ray, which revealed that HSC performed better than TVS and HSG with regard incorporates the use of a contrast material. It is performed on women to endometrial abnormalities. On the other hand, HSG outdid HSC for who are having problems in conceiving or are having recurring the diagnosis of tubal obstruction. It was concluded that HSG may not miscarriages. In addition, it is performed to ascertain the existence detect sub-serosal and intramural fibroids. However, it may diagnose of uterine tumors, adhesions and fibroids/polyps. Apart from this, it submucosal fibroids. A study was conducted by Shukla, Yadav & is also used to investigate miscarriages resulting from abnormalities Mishra14 to examine the diagnostic precision of hysteroscopy in within the uterus. Hysterosalpingography is also performed to open relation to vaginal ultrasound and hysterosalpingography in infertile fallopian tubes that are blocked and to allow the probability of future patients. A total of 60 patients participated in the study. The findings pregnancy.9 Therefore, the aim of this observational research study is of the HSG displayed a specificity of 100% and a sensitivity of 90%. to investigate the diagnostic value of hysterosalpingography (HSG) Furthermore, the positive predictive value of the test was 100% and for intracavitary and structural uterine pathologies in comparison a negative predictive value was 66.6%. HSC procedure displayed with hysteroscopy (HSC) in women with infertility. HSC and HSG variations in 65 percent cases that included endometrial polyp, are diagnostic modalities that have been performed in detecting chronic endometritis and synechiae. Apart from this, no complications intrauterine synechiae, intrauterine fibroids/polyps and mullerian occurred after performing hysteroscopy. The results also revealed congenital anomalies. Intrauterine synechiae is a uterine abnormality a moderate agreement between HSG and HSC modalities. It in which intrauterine adhesions are formed. Typically, they are was concluded that HSC showed the most accurate results when a result of a previous injury to the endometrium that can lead to diagnosing small intrauterine abrasions, in comparison to HSG and infertility.10 Intrauterine adhesions are called Asherman’s Syndrome, TVS. Makled, Farghali & Shenouda10 conducted a study to investigate and they happen when the scar tissue forms in the uterine cavity of the role of endometrial biopsy and hysteroscopy in women with the uterus. This results in the binding together of the walls of the inexplicable infertility. Diagnostic hysteroscopy was performed uterus. Intrauterine adhesions are commonly diagnosed with the on a hundred infertile women. The results revealed that 6 patients HSG procedure. Women suffering from pregnancy loss or recurrent suffered from submucous myomas, 6 had cervical stenosis and seven miscarriages (RM) are suspected to be diagnosed with congenital endured intrauterine synechiae. In addition, 15 were diagnosed with uterine anomalies.11 HSG remains a beneficial procedure for the endometrial
Recommended publications
  • Hysteroscopy with Dilation and Curretage (D & C)
    501 19th Street, Trustees Tower FORT SANDERS WOMEN’S SPECIALISTS 1924 Pinnacle Point Way Suite 401, Knoxville Tn 37916 P# 865-331-1122 F# 865-331-1976 Suite 200, Knoxville Tn 37922 Dr. Curtis Elam, M.D., FACOG, AIMIS, Dr. David Owen, M.D., FACOG, Dr. Brooke Foulk, M.D., FACOG Dr. Dean Turner M.D., FACOG, ASCCP, Dr. F. Robert McKeown III, M.D., FACOG, AIMIS, Dr. Steven Pierce M.D., Dr. G. Walton Smith, M.D., FACOG, Dr. Susan Robertson, M.D., FACOG HYSTEROSCOPY WITH DILATION AND CURRETAGE (D & C) Please read and sign the following consent form when you feel that you completely understand the surgical procedure that is to be performed and after you have asked all of your questions. If you have any further questions or concerns, please contact our office prior to your procedure so that we may clarify any pertinent issues. Definition: HysterosCopy is an outpatient procedure that allows your doctor direct visualization of the inside of the uterine cavity (womb) by inserting a thin lighted telescope (hysteroscope) through the vagina (birth canal) and cervix, without making an abdominal incision. This procedure enables your doctor to examine the lining of the uterus, look for polyps, fibroids, scar tissue, blockages of the fallopian tubes, and abnormal partitions. In addition, this procedure allows your doctor to remove or surgically treat many of the abnormalities seen. Dilation and Curettage (D&C) allows your doctor to take a sample of the tissue that lines your uterus (endometrium) and/or to remove polyps, fibroid tumors, or hyperplasia. Suction D&C is used in cases of miscarriage.
    [Show full text]
  • 2021 – the Following CPT Codes Are Approved for Billing Through Women’S Way
    WHAT’S COVERED – 2021 Women’s Way CPT Code Medicare Part B Rate List Effective January 1, 2021 For questions, call the Women’s Way State Office 800-280-5512 or 701-328-2389 • CPT codes that are specifically not covered are 77061, 77062 and 87623 • Reimbursement for treatment services is not allowed. (See note on page 8). • CPT code 99201 has been removed from What’s Covered List • New CPT codes are in bold font. 2021 – The following CPT codes are approved for billing through Women’s Way. Description of Services CPT $ Rate Office Visits New patient; medically appropriate history/exam; straightforward decision making; 15-29 minutes 99202 72.19 New patient; medically appropriate history/exam; low level decision making; 30-44 minutes 99203 110.77 New patient; medically appropriate history/exam; moderate level decision making; 45-59 minutes 99204 165.36 New patient; medically appropriate history/exam; high level decision making; 60-74 minutes. 99205 218.21 Established patient; evaluation and management, may not require presence of physician; 99211 22.83 presenting problems are minimal Established patient; medically appropriate history/exam, straightforward decision making; 10-19 99212 55.88 minutes Established patient; medically appropriate history/exam, low level decision making; 20-29 minutes 99213 90.48 Established patient; medically appropriate history/exam, moderate level decision making; 30-39 99214 128.42 minutes Established patient; comprehensive history exam, high complex decision making; 40-54 minutes 99215 128.42 Initial comprehensive
    [Show full text]
  • Endometrial Biopsy | Memorial Sloan Kettering Cancer Center
    PATIENT & CAREGIVER EDUCATION Endometrial Biopsy This information describes what to expect during and after your endometrial biopsy. About Your Endometrial Biopsy During your endometrial biopsy, your doctor will remove a small piece of tissue from the lining of your uterus. The lining of your uterus is called your endometrium. This tissue is sent to the pathology department to be examined under a microscope. The pathologist will look for abnormal cells or signs of cancer. Before Your Procedure Tell your doctor or nurse if: You’re allergic to iodine. You’re allergic to latex. There’s a chance that you’re pregnant. If you still get your period and are between ages 11 and 50, you will need to take a urine pregnancy test to make sure you’re not pregnant. You won’t need to do anything to get ready for this procedure. During Your Procedure You will have your endometrial biopsy done in an exam room. You will lie on your back as you would for a routine pelvic exam. You will be awake during the procedure. Endometrial Biopsy 1/3 First, your doctor will put a speculum into your vagina. A speculum is a tool that will gently spread apart your vaginal walls, so your doctor can see your cervix (the bottom part of your uterus). Next, your doctor will clean your cervix with a cool, brown solution of povidone- iodine (Betadine® ). Then, they will put a thin, flexible tool, called a pipelle, through your cervix and into your uterus to take a small amount of tissue from your endometrium.
    [Show full text]
  • Hysteroscopy an Internal Examination of Your Womb
    We Care Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust an internal examination Hysteroscopy of your womb This information leaflet has been given to you to help answer some of the questions you may have about having a hysteroscopy. It explains the benefits, risks and alternatives of the procedure as well as what you can expect when you come to hospital. If you have any questions or concerns, please do not hesitate to speak with your doctor or nurse. What is a hysteroscopy? A hysteroscopy is a procedure which uses a fine telescope, called a hysteroscope, to examine the lining and shape of the uterus (womb cavity). It is performed either in the outpatient department or in theatre, usually as a day patient. The Consultant will discuss with you where it is best for you to have the procedure. What are the benefits of having a hysteroscopy? A hysteroscopy can help to find the cause of problems relating to: • Heavy vaginal bleeding • Irregular periods • Bleeding between periods • Bleeding after sexual intercourse • Bleeding after menopause • Persistent discharge. In some cases, once a diagnosis has been made, the hysteroscope can also be used in the treatment of the problem. We Care WPR8773 Apr 2018 Review date by: Apr 2020 For example, problems that can be treated during a hysteroscopy are: • fibroids (growths in the uterus which are not cancer) • polyps (blood-filled growths which are not cancer) • thickening of the lining of the uterus (the endometrium) • removal of displaced intrauterine contraceptive devices removal of scar tissue. What are the risks associated with a hysteroscopy? Your Consultant/Doctor will explain these risks to you before you sign or give a verbal consent for the procedure.
    [Show full text]
  • Risks of Hysteroscopy and Fractional Dilation and Curettage South Care Women's Florida
    Risks of Hysteroscopy and Fractional Dilation and Curettage South Florida Women's Care The Procedure I will be undergoing is ______________________________________________________ _________________________________________________________________________________________. 1. Damage to uterus, bowel, bladder, urinary organs: Perforation of the uterus is a small risk. If that were to occur, laparoscopy (placing a camera in the umbilicus) may need to be done to make sure the uterus wasn’t bleeding and repair any damage. Cervical stenosis (inability of the cervix to dilate) can increase the rise of uterine perforation. 2. Fluid overload: Special attention is taken to monitor exactly how much fluid goes into your uterus during the hysteroscopy. Rarely, extra fluid can accumulate in your lungs, called pulmonary edema. 3. Damage to nerves, skin: We are very careful to position your legs very gently before surgery. Rarely, the nerves in your legs can “go to sleep” during surgery and can have temporary nerve damage. 4. Infection: You are given an antibiotic during surgery to decrease any risk of infection. Rarely, infection can occur after surgery and need medicine, and even surgery to correct. 5. Need for further surgery: If your procedure involves treatment for heavy bleeding (i.e. Removing a polyp or endometrial ablation), it is possible that these procedures will not cure your underlying problem and further surgery will be needed. 6. Risks for endometrial ablation: Sometimes your cervix will not close over the device and cause the procedure to be abandoned for safety reasons. There is also risk of damage to abdominal organs. About 5-10% of ablations done need further surgery (hysterectomy) to stop heavy bleeding.
    [Show full text]
  • Dilation and Curettage (D&C)
    Fact Sheet From ReproductiveFacts.org The Patient Education Website of the American Society for Reproductive Medicine Dilation and Curettage (D&C) This fact sheet was developed in collaboration with The Society of Reproductive Surgeons “Dilation and curettage” (D&C) is a short surgical as intestines, bladder, or blood vessels, are injured. If procedure that removes tissue from your uterus (womb). any of these organs are injured, they must be repaired You may need this procedure if you have unexplained with surgery. However, if no other organs have been or abnormal bleeding, or if you have delivered a baby injured, long-term complications from a perforation are and placental tissue remains in your womb. D&C also is extremely rare and the uterus heals on its own. performed to remove pregnancy tissue remaining from can occur after a D&C. If you are not a miscarriage or an abortion. Infections pregnant at the time of your D&C, this complication How is the procedure done? is extremely rare. However, 10% of women who were D&C can be done in a doctor’s office or in the hospital. pregnant before their D&C can get an infection, usually You may be given medications to relax you or to put you within 1 week of the procedure. It may be related to a to sleep for a short time. Your doctor will slowly widen sexually transmitted infection or due to normal bacteria the opening to your uterus (cervix). Opening your cervix that pass from the vagina into the uterus during or can cause cramping.
    [Show full text]
  • The Role of Hysteroscopy in Diagnosing Endometrial Cancer
    The role of hysteroscopy in diagnosing endometrial cancer Certain hysteroscopic findings correlate with the likelihood of endometrial carcinoma—and the absence of pathology. Here is a breakdown of hysteroscopic morphologic findings and hysteroscopic-directed biopsy techniques. Amy L. Garcia, MD or more than 45 years, gynecologists He demonstrated the advantages of using have used hysteroscopy to diagnose hysteroscopy and directed biopsy in the eval- F endometrial carcinoma and to asso- uation of abnormal uterine bleeding (AUB) to ciate morphologic descriptive terms with obtain a more accurate diagnosis compared visual findings.1 Today, considerably more with dilation and curettage (D&C) alone clinical evidence supports visual pattern rec- (sensitivity, 98% vs 65%, respectively).2 ognition to assess the risk for and presence of Also derived from this work is the clini- IN THIS endometrial carcinoma, improving observer- cal application of the “negative hysteroscopic ARTICLE dependent biopsy of the most suspect lesions view” (NHV). Loffer used the following cri- (VIDEO 1). teria to define the NHV: good visualization Hysteroscopic In this article, I discuss the clinical evo- of the entire uterine cavity, no structural classification lution of hysteroscopic pattern recognition abnormalities of the cavity, and a uniformly of endometrial Ca of endometrial disease and review the visual thin, homogeneous-appearing endometrium findings that correlate with the likelihood of without variations in thickness (TABLE 1). The this page endometrial carcinoma. In addition, I have last criterion can be expected to occur only in provided 9 short videos that show hystero- the early proliferative phase or in postmeno- Negative scopic views of various endometrial patholo- pausal women.
    [Show full text]
  • A Critical Systematic Review and Meta-Analyses of Risk Factors for Fertility Problems in a Globalized World
    medRxiv preprint doi: https://doi.org/10.1101/2021.05.06.21256676; this version posted May 8, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Looking beyond the obvious: a critical systematic review and meta-analyses of risk factors for fertility problems in a globalized world Authors: R.R. Bayoumi1*, J. Boivin2*, H.M. Fatemi3, L. Hurt4, G.I. Serour5, S. van der Poel6 and C. Venetis7. 1* Corresponding author: PhD Student, School of Psychology, Cardiff University, Cardiff, Wales, UK; Takemi Fellow, Takemi Program in International Health, Harvard T.H. Chan School of Public Health, Boston, USA, [email protected] 2* Corresponding author: Professor of Psychology, School of Psychology, Cardiff University, Cardiff, Wales, UK, [email protected] 3: Professor of Obstetrics and Gynecology, Group Medical Director, ART Fertility Clinics, Abu Dhabi, UAE 4: Senior Lecturer, Division of Population Medicine, Cardiff University School of Medicine, Cardiff, Wales, UK 5: Professor of Obstetrics and Gynecology, Al Azhar University, Cairo, Egypt 6: Independent Consultant, Route de la Capite, Geneva, Switzerland 7: Associate Professor, Centre for Big Data Research in Health, University of New South Wales, Sydney, Australia Abstract Background: Well-established risk factors for fertility problems such as smoking have been included in fertility awareness efforts globally. However, these efforts neglect risks that women in low and middle-income countries (LMIC) face. Objective: To address this gap, we identified eight risk factors affecting women in LMIC and the aim of the current review was to estimate the impact of these risks on fertility.
    [Show full text]
  • Hysteroscopy Vs. Transvaginal Ultraultrasonography in the Diagnosis of Endometrial Lesions
    Caspian J Reprod Med, 2016, 2(1): 21-26 Caspian Journal of Reproductive Medicine Journal homepage: www.caspjrm.ir Original article Hysteroscopy vs. transvaginal ultraultrasonography in the diagnosis of endometrial lesions Zinatossadat Bouzari 1, Shahla Yazdani2, Sedigheh Esmailzadeh 2,*, Roza Shahhoseini3, Ali Fazli4, Mojgan Naeimi rad4 1Cellular & Molecular Biology Research Center, Department of Obstetrics & Gynecology, Babol University of Medical Sciences, Babol, Iran 2Infertility and Reproductive Health Research Center, Health Research Institute & Department of Obstetrics & Gynecology, Clinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran 3Department of Obstetrics & Gynecology, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran 4Clinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol-Iran Received: 11 Dec 2015 Accepted: 10 Mar 2016 Abstract Background: Abnormal uterine bleeding (AUB) is the most common gynecological problems that many factors are involved in its creation. Two common methods used to diagnose uterine lesions are vaginal ultraultrasonography and hysteroscopy. The aim of this study was to evaluate the diagnostic value of transvaginal ultraultrasonography and hysteroscopy in the diagnosis of intrauterine lesions leading to the AUB. Methods: A cross-sectional study was performed on 203 premenopausal post-menopausal women with complaints of abnormal uterine bleeding. A transvaginal ultraultrasonography was performed from the eligible subjects. In the second visit, a hysteroscopy was done and during the hysteroscopy procedure an endometrial biopsy was obtained from all the women. Pathology was considered as the gold standard and sensitivity, specificity, positive predictive value and negative predictive value were calculated for both methods using the Cat maker software.
    [Show full text]
  • Hysteroscopy Dilation and Curettage
    Hysteroscopy Dilation and Curettage Technique Procedure involves using a hysteroscope to place microinserts within the opening of the fallopian tubes from within the uterus. These inserts block the fallopian tubes for the purpose of permanent sterilization. Incisions No incisions are required for this procedure Operative Time Operative times vary greatly depending on the findings at the time of surgery. Your surgeon will proceed with safety as his/her first priority. Average times range from 15-30 minutes. Anesthesia • Local anesthesia or • Local anesthesia + IV sedation Preoperative Care • Schedule your case immediately after your period. • Your doctor will recommend that you take a hormonal medicine to thin the lining of your uterus prior to this procedure. • Nothing by mouth after midnight Hospital Stay • Office procedure • Day surgery Postoperative Care These guidelines are intended to give you a general idea of your postoperative course. Since every patient is unique and has a unique procedure, your recovery may differ. • Anti-inflammatory pain medicine, such as ibuprofen, naproxen, etc., is usually required for the first several days. Most patients do not need narcotics. • Driving is allowed once you have cleared anesthesia. • If they desire, patients may return to work on the day of the procedure. • You must use a form of reversible contraception until you undergo a hysterosalpingogram (HSG). This x-ray test will be performed 3 months after your procedure and will confirm that your fallopian tubes are occluded. 1700 6th Avenue South ● Birmingham, AL 35249 ● (205) 934-9999 .
    [Show full text]
  • STOP Performing Dilation and Curettage for the Evaluation Of
    STOP/START Diagnostic hysteroscopy spies polyp previously missed on transvaginal ultrasound and dilation and curettage. STOP performing dilation and curettage for the evaluation of abnormal uterine bleeding START performing in-office hysteroscopy to identify the etiology of abnormal uterine bleeding }expert commentary her treatment she had a 3-year history of Amy Garcia mD, Director, Center for abnormal vaginal bleeding. Results from con- Women’s Surgery and Garcia Institute for management secutive pelvic ultrasounds indicated that the Hysteroscopic Training, Albuquerque, and Clinical Assistant Professor, Department patient had progressively thickening endome- obg r of Obstetrics and Gynecology, University trium (from 1.4 cm to 2.5 cm to 4.7 cm). In-office O r f of New Mexico School of Medicine, Albu- E biopsy was negative for endometrial pathology. f querque. Dr. Garcia serves on the OBG ie An ultimate dilation and curettage (D&C) was K ManageMent Board of Editors. On the Web aig Dr. Garcia reports receiving grant support from Hologic; CASe In-office hysteroscopy spies being a consultant to Conceptus, Boston Scientific, Ethicon : Cr 12 intraoperative Endosurgery, IOGYN, Minerva, Hologic, Smith & Nephew, previously missed polyp ation videos from and Karl Storz Endoscopy; and being a member of the r A 51-year-old woman with a history of breast Dr. Garcia, at speakers’ bureau for Conceptus, Karl Storz Endoscopy, and ust ll obgmanagement.com cancer completed 5 years of tamoxifen. During Ethicon Endosurgery. I 44 OBG Management | June 2013 | Vol. 25 No. 6 obgmanagement.com performed with negative histologic diagnosis. FIGURE consecutive ultrasounds evaluating The patient is seen in consultation, and abnormal bleeding the ultrasound images are reviewed (FIGURE).
    [Show full text]
  • The Woman with Postmenopausal Bleeding
    THEME Gynaecological malignancies The woman with postmenopausal bleeding Alison H Brand MD, FRCS(C), FRANZCOG, CGO, BACKGROUND is a certified gynaecological Postmenopausal bleeding is a common complaint from women seen in general practice. oncologist, Westmead Hospital, New South Wales. OBJECTIVE [email protected]. This article outlines a general approach to such patients and discusses the diagnostic possibilities and their edu.au management. DISCUSSION The most common cause of postmenopausal bleeding is atrophic vaginitis or endometritis. However, as 10% of women with postmenopausal bleeding will be found to have endometrial cancer, all patients must be properly assessed to rule out the diagnosis of malignancy. Most women with endometrial cancer will be diagnosed with early stage disease when the prognosis is excellent as postmenopausal bleeding is an early warning sign that leads women to seek medical advice. Postmenopausal bleeding (PMB) is defined as bleeding • cancer of the uterus, cervix, or vagina (Table 1). that occurs after 1 year of amenorrhea in a woman Endometrial or vaginal atrophy is the most common cause who is not receiving hormone therapy (HT). Women of PMB but more sinister causes of the bleeding such on continuous progesterone and oestrogen hormone as carcinoma must first be ruled out. Patients at risk for therapy can expect to have irregular vaginal bleeding, endometrial cancer are those who are obese, diabetic and/ especially for the first 6 months. This bleeding should or hypertensive, nulliparous, on exogenous oestrogens cease after 1 year. Women on oestrogen and cyclical (including tamoxifen) or those who experience late progesterone should have a regular withdrawal bleeding menopause1 (Table 2).
    [Show full text]